Cancer
Stomach cancer in Bengbu
蚌埠 胃癌
1 hospital in Bengbu
Order: papers led on stomach cancer, 2021–2025, then A–Z. Research activity, not a rating of care.
Only hospitals listed for stomach cancer: those with enough papers or registered trials on it in the records this site uses. Other hospitals in Bengbu may also treat it. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first.
- 31 papers led
Stomach cancer in every city Bengbu on the disease page, with the national map
open trials on stomach cancer with a hospital in Bengbu
Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 8 Nov 2026, with a listed hospital in Bengbu as lead sponsor or study site. 1 of them are led by a hospital in Bengbu. Check the registry for the current status. Whether someone can take part is decided by the study team.
Only trials registered on ClinicalTrials.gov are counted. Trials registered only in China’s own registry (ChiCTR) are not.
- RecruitingA Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
- Phase
- Phase 3
- Started
- 2024-11
- Registry
- NCT06532006
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 34 listed hospitals as study sitesBeijing, Bengbu, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Lanzhou, Nanchang, Nanjing, Qingdao, Shanghai, Shijiazhuang, Taiyuan, Tianjin, Urumqi, Xiamen, Xuzhou, Yinchuan, Zhengzhou
- RecruitingA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- Phase
- Phase 1/Phase 2
- Started
- 2022-01
- Registry
- NCT05150691
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 34 listed hospitals as study sitesAnyang, Beijing, Bengbu, Changchun, Changsha, Chongqing, Guangzhou, Hangzhou, Hefei, Jinan, Nanning, Shanghai, Shenyang, Shijiazhuang, Tianjin, Wenzhou, Wuhan, Wuxi, Xi'an, Xiamen, Xuzhou, Yantai, Zhengzhou
- RecruitingApatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer
- Phase
- Phase 2
- Started
- 2017-09
- Registry
- NCT03219593
Age 65 years to Not stated (registered criteria)
Led by First Affiliated Hospital of Bengbu Medical UniversityBengbu
Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.
Disease research in Bengbu
Each number is papers led on that disease, 2021–2025. “Open” counts open trials the hospital leads. Hospitals A–Z; this is not a ranking.
A blank cell means no papers or trials were found in these records. It does not mean the hospital does not treat that disease.
| Cancer | Blood disorders | Other diseases | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital | Nasopharyngeal carcinoma | Oesophageal squamous cell carcinoma | Hepatocellular carcinoma | Stomach cancer | Hepatoblastoma | Retinoblastoma | Chordoma | Osteosarcoma | Gastrointestinal stromal tumour | Neuroblastoma | Ewing sarcoma | Multiple myeloma | B-cell acute lymphoblastic leukaemia | Aplastic anaemia | Haemophagocytic lymphohistiocytosis | Beta thalassaemia | Haemophilia A | Atypical haemolytic uraemic syndrome | Thrombotic thrombocytopenic purpura | Fanconi anaemia | Neuromyelitis optica spectrum disorder | IgG4-related disease | Myasthenia gravis | Moyamoya disease | Wilson disease | Biliary atresia | Anti-NMDA receptor encephalitis | Takayasu arteritis | Hepatic echinococcosis | Idiopathic pulmonary fibrosis | Lymphangioleiomyomatosis | Amyotrophic lateral sclerosis | Spinal muscular atrophy | Fabry disease | Pompe disease | Duchenne muscular dystrophy | Behçet disease | Alport syndrome | IgA nephropathy | Gaucher disease | Niemann–Pick disease type C | Osteogenesis imperfecta | Primary biliary cholangitis | Primary sclerosing cholangitis | Congenital diaphragmatic hernia | Hirschsprung disease | Inherited epidermolysis bullosa | Hereditary angioedema | Familial adenomatous polyposis | Leber hereditary optic neuropathy | Majeed syndrome | NGLY1 deficiency | ISG15 deficiency | Shortlist |
| First Affiliated Hospital of Bengbu Medical University蚌埠医学院第一附属医院 | 8 | 51 open | 41 | 311 open | 2 | none | none | 0 | 1 | 1 | none | 5 | none | none | none | 1 | 4 | none | none | none | none | none | 0 | none | none | none | none | none | 0 | 1 | none | 2 | none | none | none | none | 0 | none | 2 | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | |
Column labels are short names. Choose one to open that disease in Bengbu.
- Nasopharyngeal carcinoma 8
- Oesophageal squamous cell carcinoma 51 open
- Hepatocellular carcinoma 41
- Stomach cancer 311 open
- Hepatoblastoma 2
- Osteosarcoma 0
- Gastrointestinal stromal tumour 1
- Neuroblastoma 1
- Multiple myeloma 5
- Beta thalassaemia 1
- Haemophilia A 4
- Myasthenia gravis 0
- Hepatic echinococcosis 0
- Idiopathic pulmonary fibrosis 1
- Amyotrophic lateral sclerosis 2
- Behçet disease 0
- IgA nephropathy 2
- Primary biliary cholangitis 0
Other cities nearby
Straight-line distance from the city centre; counts are hospitals listed for stomach cancer.
Counts are listed hospitals only, not every hospital in each city.
Where these numbers come from
Papers
English-language PubMed papers, 2021–2025, where the first or last author lists the hospital first. Definitions
Trials
ClinicalTrials.gov records with the hospital as lead sponsor or site, as of 8 Nov 2026. Search Bengbu on ClinicalTrials.gov
Locations
Locations are shown at city centres. Check the hospital’s website for its address.